Press Releases
ACCURI CYTOMETERS ADDS TWO HIGH PROFILE LIFE SCIENCES EXECUTIVES TO
ITS BOARD OF DIRECTORS
Ann Arbor, MI ’Äì June 25, 2007 ’Äì Accuri Cytometers, Inc., a life sciences
company developing revolutionary bench-top flow cytometer systems,
today announced the appointment of Daniel J. Calvo and George W. Dunbar
to newly created positions on its Board of Directors.
’ÄúWe are fortunate to have recruited these two outstanding individuals
to our Board who are located in our own community,’Äù said Jennifer Baird,
Chief Executive Officer of Accuri. ’ÄúGeorge and Dan have a wealth of
successful strategic and operational experience in growing life sciences
organizations and taking them to the next level, with expertise spanning
early stage to global scale organizations. The fact that our region
increasingly is home to senior executives of this caliber is a testament
to the vitality of the Ann Arbor life sciences sector. Dan’Äôs and George’Äôs
proximity to Accuri should enable us to benefit from their expertise
on an ongoing basis as we continue our preparations for the commercial
launch of our Accuri C6 Flow Cytometer’Ñ¢.’Äù
Press
Release PDF file
ACCURI CYTOMETERS ANNOUNCES COMPLETION OF $5 MILLION SERIES B FINANCING
LED BY BAIRD VENTURE PARTNERS
Ann Arbor, MI - April 16, 2007
Accuri Cytometers Inc., a life sciences
company developing revolutionary bench-top flow cytometer systems,
today announced the completion of a $5 million Series B financing
led by Baird Venture Partners (BVP), the U.S.-based venture capital
fund of Baird Private Equity. Arboretum Ventures of Ann Arbor co-led
the financing. Both firms are new investors in Accuri, which intends
to use the Series B proceeds for the ongoing testing and upcoming
commercial launch of the Accuri C6 Flow Cytometer’Ñ¢ System. Pete Shagory
of BVP and Tim Petersen of Arboretum will join the company’Äôs Board
of Directors.
Series B Press Release PDF file |
